Over-expressed CD 147 may be a reminder of tumor progression in cervical lesions : an immunohistochemical investigation with 494 cases
Wen-Ting Huang,Li Gao,Rong-Quan He,Jie Ma,Kang-Lai Wei,Gang Chen
2017-01-01
Abstract:Background: CD147 plays a pivotal in the process of many malignancies. It remains unclear whether CD147 expression has clinical significance with cervical lesions. The current research was aimed to assess the expression of CD147 and investigate its relevance with the tumorigenesis and clinicopathological progression of cervical cancer. Materials and methods: Immunohistochemistry was conducted to evaluate the expression of CD147 within a total of 494 cases of cervical lesions, which were composed of chronic cervicitis (n=54), condyloma acuminatum (CA, n=42), carcinoma in situ (CIS, n=38), adenocarcinoma (n=63), squamous cell carcinoma (SCC, n=263) and adenosquamous carcinoma (n=34). SPSS 22.0 was used to analyze the relationship of CD147 expression and clinicopathological features of cervical lesions. CBioPortal was used to assess the OncoPrint of CD147 based on the data from The Cancer Genome Atlas (TCGA), and the prognostic value of CD147 in cervical cancer was shown by Oncolnc. Results: CD147 expression showed a positive rate of 22.2%, 31.0%, 42.1%, 55.6%, 66.5% and 64.7% from chronic cervicitis, CA, CIS to adenocarcinoma, SCC and adenosquamous carcinoma, respectively. CD147 expression level was statistically higher in cancer than non-cancerous tissues (P<0.001). Results from Spearman correlation test confirmed that CD147 had positive correlation with age, lymph node metastasis, FIGO stage, TNM stage, as well as pathological grade (all P<0.05) in adenocarcinoma. As for SCC, CD147 was positively related to lymph node metastasis, FIGO stage, TNM stage and pathological grade (all P<0.001). In adenosquamous carcinoma, a positive correlation was observed between CD147 and lymph node metastasis, FIGO stage and TNM stage (all P<0.05). Furthermore, Gene alteration of 79 among 307 cases (26%) was shown by CBioPortal based on RNA-seq data. Conclusions: CD147 may have a significant effect on the tumorigenesis and progression of cervical cancer, and it is anticipated to be a potential diagnostic and therapeutic biomarker.